Reuters logo
BRIEF-Proteon Therapeutics Q3 ‍loss per share $1.08​
November 7, 2017 / 1:33 PM / a month ago

BRIEF-Proteon Therapeutics Q3 ‍loss per share $1.08​

Nov 7 (Reuters) - Proteon Therapeutics Inc

* Proteon Therapeutics announces third quarter 2017 financial results

* Remain on-track to complete enrollment in Q1 of 2018 in patency-2, co’s second phase 3 clinical trial of vonapanitase​

* Qtrly ‍loss per share $1.08​

* Expects its cash, cash equivalents, available-for-sale investments will be sufficient to fund its operations into Q4 of 2019,

* Q3 earnings per share view $-0.39 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below